英国《自然·医学》:学术不端频发,中国直面挑战
11 08 2006年研究领域被广为报道。对于仍然努力在全世界赢得信誉度的中国生命科学研究,
不断出现的对剽窃、篡改数据和伪造简历等行为的指控已经发出了一个严重的警
告。中国政府最终也无法对此等闲视之。
一点转机。三月份,清华大学开除了简历造假的医学教授刘辉,这位清华医学院
前任院长助理被发现把别人的论文归于自己名下。随后,在六月末,上海的同济
大学解聘了生命科学学院前院长杨杰,原因据称也是窃取其同事的数据。
则提出了诸如随机抽取基金评委的方式来对付申请科研经费时的裙带作风。科技
部在7月10日还宣布将建立一个独立的机构来监督研究项目的经费使用情况。
域既有信息技术,也包括生物医药研究。其中,生命科学领域的研究似乎特别容
易发生欺诈行为。新语丝网站的主持人方是民(方舟子)指出,这是因为这一领
域的实验结果更难精确地重复。方舟子从前曾是一位生物化学研究者,目前,他
主持一个名为新语丝的网站(www.xys.org),列举了大量学术不端事件。在最近
发生的6起生命科学领域涉嫌造假的案例中,有5起最初来自新语丝刊登的举报和
揭发材料。
是中国在急于取得生命科学领域研究进展的同时,没有建立一套强有力的系统来
充分管理和监督科研经费并提防不端行为。获取科研经费的压力可能会导致一些
科学家伪造研究成果。“过去,这个领域的资助额和竞争程度都要少得多,”
施一公说。
增长了400%,达到了130亿元(16亿美元)。中国庞大的病人资源和廉价的生物
技术科研人员一直以来对国际合作者很有吸引力,但是最近的事件已经让海外中
国科学家开始采取小心的态度。
同行合作时要格外小心,”美国堪萨斯大学药学院的研究人员Lu
Hong表示。
经常调查对各种不端行为的指控,并公开整肃那些被发现有过失的人。
衡量成果的指标,而不仅仅是在影响因子高的期刊上发表的论文数量。“当科研
经费和科研奖励被给予真正的科学创造,生命科学领域中的造假行为在很大程度
上就会得到避免。”
Frequent cases force China to face up to scientific fraud
Frequent cases force China to face up to scientific fraud
months: for
China’s biomedical research, still struggling for global
credibility,
the frequent accusations of plagiarism, falsified data and
fabricated
resumes spell out a serious warning—one that the government
is
finally preparing to heed.
or even
acknowledge cases of misconduct. But in early March,
Beijing-based
Tsinghua University fired Hui Liu, a professor of medicine, after
he
was found to have claimed another researcher’s papers as his own
on
his resumé. Then, in late June, Tongji University in
Shanghai
dismissed Jie Yang, dean of the university’s school of life
sciences,
for allegedly stealing his colleagues’ data.
ethics
committee to discipline researchers, and the Ministry of Science
and
Technology has proposed measures such as the random selection of
grant
reviewers to combat nepotism. Most recently, Yong Shang, China’s
vice
minister of science and technology, announced on 10 July that
the
ministry plans to set up an independent agency to monitor the
research
projects it funds.
the past
year in fields ranging from information technology to
biomedical
research. But research in the life sciences may be
particularly
susceptible to fraud because it is often difficult to reproduce
exactly,
says Shimin Fang, a former biochemistry researcher. Fang now runs
a
website called New Threads (www.xys.org) that lists allegations
of
fraud and identified five of the six cases, including that of Hui
Liu.
to
adequately manage and audit grants and to safeguard against
misconduct,
says Yigong Shi, professor of molecular biology at Princeton
University.
The pressure to secure grants may have led some scientists to
fabricate research, he says.“Previously, the funding and the level
of
competition in the field were much lower.”
in the
past five years to RMB13 billion (US$1.6 billion). China’s large
pool
of patients and cheap skilled biotech researchers have been
highly
attractive for collaborators outside China, but the recent
incidents
have struck a note of caution for Chinese scientists abroad.
would be
particularly cautious when cooperating with our domestic
counterparts,”
says Hong Lu, a researcher at Kansas University Medical
Center.
routinely
investigate allegations of misconduct and openly discipline
those
found to be guilty, researchers say.
develop other
measures of success rather than rely exclusively on publications
in
journals with high impact factors. “When the funding and rewards
are
endowed to the true scientific excellence,” he says, “fraud in
life
science can be largely avoided.”